RxSight, Inc. (RXST) Balance Sheet

The steady erosion of retained earnings alongside a broadly flat equity base suggests that paid-in capital, not operations, is absorbing the cumulative losses. The reported equity trajectory therefore reflects a business that is consuming its funding reserves over time, which warrants monitoring of how long the current equity cushion can absorb continued net losses. Investors should view the stability in total equity as a function of past capital raises rather than evidence of improving fundamentals.

A current ratio above 4 remains comfortable on its face, but the decline from above 14 reflects growing current liabilities relative to current assets over the period. Cash balances have been volatile, including a drop to $13.4M in 2026Q2 before a rebound, which suggests the liquidity buffer is sensitive to working capital timing. This pattern may indicate that the company's short-term resources warrant close tracking against its quarterly operating losses.

The consistently low debt-to-equity ratio implies that refinancing risk is not a primary balance sheet concern at current levels. Because debt is small relative to equity, the company's financial flexibility appears driven more by its equity and cash position than by borrowing capacity. Investors should note that low leverage does not offset the operating losses reflected elsewhere in the financial statements.

A stable PP&E base alongside no reported goodwill indicates that the asset base is not burdened by acquisition-driven intangibles, lowering the risk of future impairment charges. Total asset fluctuations appear to reflect working capital and cash movements rather than capacity expansion. This profile suggests capital intensity is limited, although the asset base alone does not establish the company's earnings power.

Sporadic deferred revenue balances suggest that advance billings or service contracts are not a consistent feature of the reported business, so they provide limited forward signal. The recent uptick may indicate some improvement in prepaid commitments, though a short series of positive readings is insufficient to confirm a trend. Investors should treat deferred revenue as an early indicator to monitor rather than a basis for forecasting.